A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)

NCT04791514 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Low enrolment

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Treprostinil Palmitil

Sponsor

Insmed Incorporated